UNITED
STATES
SECURITIES AND
EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT TO SECTION 13 OR
15(D) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): June 15, 2016
Alliance BioEnergy
Plus, Inc.
(Exact Name of
Registrant as Specified in its Charter)
Nevada | 000-54942 | 45-4944960 | ||
(State or Other Jurisdiction of | (Commission File | (I.R.S. Employer | ||
Incorporation) | No.) | Identification No.) | ||
400 North Congress Avenue, Suite 130, West Palm | 77057 | |||
Beach, FL | ||||
(Address of Principal Executive Offices) | (Zip Code) |
Registrants telephone number, including area code: (888) 607-3555
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
TABLE OF CONTENTS
Item 5.07 | Item 5.07 Submission of Matters to a Vote of Security Holders | |
Item 9.01 | Financial Statements and Exhibits |
SIGNATURES
Item 5.07 Submission of Matters to a Vote of Security Holders
Alliance BioEnergy Plus, Inc. (the Company) held its 2016 Annual Meeting of Shareholders on June 15, 2016. There were 52,966,742 outstanding shares eligible to vote as of May 23, 2016, the record date for the 2016 Annual Meeting and 35,695,303 shares were present either in person or by proxy at the meeting (which represented 67.39% of the issued and outstanding shares eligible to vote). At the meeting, the following actions were taken:
(i) The Companys shareholders elected four directors to the Companys Board of Directors for terms expiring at the Annual Meeting in the year 2017. The directors elected, as well as the number of votes cast for and votes withheld for each individual are set forth below:
Nominee | Votes For | % Voted For |
Withheld | % Withheld |
Daniel de Liege | 35,027,199 | 98.13% | 668,104 | 1.87% |
Charles F. Sills | 35,314,658 | 98.93% | 380,645 | 1.07% |
George D. Bolton | 35,314,658 | 98.93% | 380,645 | 1.07% |
Troy Lorenz | 30,455,125 | 85.32% | 5,240,178 | 14.68% |
The Company decided not to nominate Joseph Walsh for reelection as a director and, as a result, his term as a director expired as of June 15, 2016, the date of the Companys 2016 Annual Meeting.
(ii) The Companys shareholders approved a proposal to increase the Companys authorized capital from 110,000,000 to 510,000,000 shares comprising 500,000,000 shares of Common Stock par value $0.001 and 10,000,000 shares of Preferred Stock par value $0.001 with the following votes:
Amount | ||
Votes for approval: | 23,993,100 | |
Votes against: | 11,562,766 | |
% Voted for approval | 67.22% | |
% Voted against approval: | 32.39% | |
Abstentions: | 139,437 | |
% Abstentions: |
0.39% |
(iii) The Companys shareholders approved a proposal to ratify the Audit Committees appointment of Paritz & Company, P.A. as the Companys independent registered public accounting firm for the year ending December 31, 2016, with the following votes:
Amount | ||
Votes for approval: | 35,438,045 | |
Votes against: | 246,808 | |
% Voted for approval | 99.28% | |
% Voted against approval: | 0.69% | |
Abstentions: | 10,400 | |
% Abstentions: | 0.03% |
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
None.
SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Alliance BioEnergy Plus, Inc. | |
/s/ Daniel de Liege | |
By: | |
Name: Daniel de Liege | |
Title: President |
Dated: June 16, 2016